Lower Risk

Pharmaceutical

Biosimilars Development Scientist

AI is poised to impact Biosimilars Development Scientists primarily through enhanced data analysis, predictive modeling, and automation of routine laboratory tasks. Machine learning models can accelerate the analysis of complex biological data, predict biosimilar efficacy, and optimize manufacturing processes. LLMs can assist in literature reviews and regulatory document preparation. Computer vision can automate quality control processes.

Top risks:

Design and execute experiments to characterize biosimilar candidates40%
Analyze complex biological data (e.g., protein structure, glycosylation patterns, bioactivity assays)60%
Develop and optimize cell culture and purification processes for biosimilar production50%

Pharmaceutical

Medical Writer

AI, particularly large language models (LLMs), will significantly impact medical writing by automating the generation of drafts, summarizing research, and ensuring regulatory compliance. Computer vision may assist in analyzing medical images for inclusion in reports. However, tasks requiring critical evaluation of clinical data and strategic communication with stakeholders will remain human-centric.

Top risks:

Writing clinical study reports70%
Developing regulatory documents (e.g., INDs, NDAs)60%
Creating marketing materials for pharmaceutical products50%

Side-by-Side Metrics

Metric	Biosimilars Development Scientist	Medical Writer
Risk Score	70%	72%
Risk Level	Critical Risk	Critical Risk
Timeline	5-10 years	2-5 years
Category	Pharmaceutical	Pharmaceutical
Tasks at Risk	7 tasks	7 tasks
Skills at Risk	5 skills	5 skills
Safe Skills	5 skills	5 skills

Risk Comparison

Biosimilars Development Scientist70%

Medical Writer72%

Biosimilars Development Scientist has 2 percentage points lower risk than Medical Writer.

Tasks at Risk

Biosimilars Development Scientist Tasks at Risk

Design and execute experiments to characterize biosimilar candidates40%

5-10 years

Analyze complex biological data (e.g., protein structure, glycosylation patterns, bioactivity assays)60%

2-5 years

Develop and optimize cell culture and purification processes for biosimilar production50%

5-10 years

Prepare regulatory documents (e.g., IND, BLA) for submission to regulatory agencies40%

5-10 years

Conduct quality control testing of biosimilar products70%

2-5 years

Medical Writer Tasks at Risk

Writing clinical study reports70%

2-5 years

Developing regulatory documents (e.g., INDs, NDAs)60%

2-5 years

Creating marketing materials for pharmaceutical products50%

5-10 years

Summarizing scientific literature and research findings80%

2-5 years

Ensuring accuracy and consistency of medical information40%

5-10 years

Skills Comparison

Shared AI-Resistant Skills(valuable in both careers)

Complex problem-solvingEthical judgment

Biosimilars Development Scientist -- Safe Skills

Critical thinkingComplex problem-solvingCollaborationCommunicationEthical judgment

Biosimilars Development Scientist -- Skills at Risk

Data analysisExperimental designQuality control testingRegulatory document preparationRoutine record keeping

Medical Writer -- Safe Skills

Critical evaluation of clinical dataStrategic communicationRelationship buildingEthical judgmentComplex problem-solving

Medical Writer -- Skills at Risk

SummarizationDraftingData extractionBasic editingFormatting

Recommendations